Description
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
Purity | ≥70% |
---|---|
Formula | C16H14N2O4 |
Formula Wt. | 298.29 |
Appearance | Red Powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
Pipaón C, Gutierrez P, Montero JC, et al. Mitogen-activated protein kinase routes as targets in the action of diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells. Mol Cancer Ther. 2002 Aug;1(10):811-9. PMID: 12492114.
α-Linked disaccharide composed of α-glucose u...
Peptide fragment, renin substrate, precursor to...
α2-adrenergic agonist.
Highly selective inhibitor
PP2A activator, Sphk1 and PKC inhibitor.
SERCA inhibitor.
Dicarboxylic acid found in Arabidopsis; PPARγ ...
Endogenous peptide, involved in stress signalin...
Ansamycin; bacterial DNA-dependent RNA polymera...
ROCK inhibitor.
Fluoroquinolone; topoisomerase IV and bacterial...
HDAC6 inhibitor.
Used to study embryonic cloning; microtubule po...
Basic phenol skeleton structure found in variou...
Induces activation of Nrf2; inhibits apoptosis ...
Protease substrate.
Precursor in the synthesis of hydroquinone, ant...
Adenosine antagonist, PDE inhibitor.
Ca2+ ATPase and ATP-sensitive K+ channel activa...
GSK-3β inhibitor.